Hengehold Capital Management LLC Abb Vie Inc. Transaction History

Hengehold Capital Management LLC

$937 Million
Q1 2024

A detailed history of Hengehold Capital Management LLC transactions in Abb Vie Inc. stock. As of the latest transaction made, Hengehold Capital Management LLC holds 25,413 shares of ABBV stock, worth $4.23 Million. This represents 0.49% of its overall portfolio holdings.

Number of Shares

25,413

Previous 25,640 0.89%

Holding current value

$4.23 Million

Previous $3.97 Million 16.46%

% of portfolio

0.49%

Previous 0.47%

27 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 Apr 15, 2024	SELL	$159.82 - $182.1 $36,279 - $41,336	-227 Reduced 0.89%	25,413 $4.63 Million
Q4 2023 Jan 19, 2024	BUY	$137.6 - $154.97 $36,326 - $40,912	264 Added 1.04%	25,640 $3.97 Million
Q3 2023 Oct 13, 2023	SELL	$133.59 - $154.65 $61,451 - $71,139	-460 Reduced 1.78%	25,376 $3.78 Million
Q2 2023 Jul 17, 2023	SELL	$132.51 - $164.9 $23,984 - $29,846	-181 Reduced 0.7%	25,836 $3.48 Million
Q1 2023 Apr 19, 2023	BUY	$144.61 - $166.54 $5,929 - $6,828	41 Added 0.16%	26,017 $4.15 Million

Q4 2022 Jan 19, 2023	BUY	$138.31 - $165.87 $219,912 - $263,733	1,590 Added 6.52%	25,976 $0
Q3 2022 Oct 21, 2022	BUY	$134.21 - $153.93 $47,376 - $54,337	353 Added 1.47%	24,386 $3.27 Million
Q2 2022 Jul 22, 2022	BUY	$137.62 - $174.96 $60,552 - $76,982	440 Added 1.86%	24,033 $3.68 Million
Q1 2022 Apr 27, 2022	SELL	$131.98 - $163.75 $20,456 - $25,381	-155 Reduced 0.65%	23,593 $3.83 Million
Q4 2021 Feb 02, 2022	BUY	$107.43 - $135.93 $10,205 - $12,913	95 Added 0.4%	23,748 $3.22 Million
Q3 2021 Nov 03, 2021	BUY	$106.4 - $120.78 $41,496 - $47,104	390 Added 1.68%	23,653 $2.55 Million
Q2 2021 Aug 04, 2021	BUY	$105.21 - $117.21 $38,506 - $42,898	366 Added 1.6%	23,263 $2.62 Million
Q1 2021 Apr 30, 2021	SELL	$102.3 - $112.62 $44,398 - $48,877	-434 Reduced 1.86%	22,897 $2.48 Million
Q4 2020 Feb 09, 2021	BUY	$80.49 - $108.67 $49,018 - $66,180	609 Added 2.68%	23,331 $2.5 Million
Q3 2020 Nov 09, 2020	SELL	$85.91 - $100.83 $19,329 - $22,686	-225 Reduced 0.98%	22,722 $1.99 Million
Q2 2020 Jul 31, 2020	SELL	$73.37 - $98.18 $10,198 - $13,647	-139 Reduced 0.6%	22,947 $2.25 Million
Q1 2020 Apr 22, 2020	SELL	$64.5 - $97.79 $488,458 - $740,563	-7,573 Reduced 24.7%	23,086 $1.76 Million
Q4 2019 Jan 24, 2020	BUY	$72.13 - $90.25 $42,484 - $53,157	589 Added 1.96%	30,659 $2.72 Million
Q3 2019 Oct 22, 2019	BUY	$62.98 - $75.72 $105,869 - $127,285	1,681 Added 5.92%	30,070 $2.28 Million
Q2 2019 Jul 23, 2019	BUY	$65.7 - $83.98 $19,644 - $25,110	299 Added 1.06%	28,389 $2.06 Million
Q1 2019 Apr 30, 2019	BUY	$77.14 - $90.79 $108,921 - $128,195	1,412 Added 5.29%	28,090 $2.26 Million
Q4 2018 Jan 22, 2019	BUY	$77.85 - $96.01 $117,164 - $144,495	1,505 Added 5.98%	26,678 $2.46 Million
Q3 2018 Oct 23, 2018	BUY	$88.91 - $98.84 $57,791 - $64,246	650 Added 2.65%	25,173 $2.38 Million
Q2 2018 Jul 20, 2018	SELL	$89.78 - $106.23 $14,005 - $16,571	-156 Reduced 0.63%	24,523 $2.27 Million
Q1 2018 Apr 17, 2018	SELL	$92.01 - $123.21 $33,399 - $44,725	-363 Reduced 1.45%	24,679 $2.34 Million
Q4 2017 Jan 26, 2018	SELL	$89.56 - $98.21 $980,771 - $1.08 Million	-10,951 Reduced 30.43%	25,042 $2.42 Million
Q3 2017 Oct 17, 2017	BUY	$69.85 - $89.22 $2.51 Million - $3.21 Million	35,993	35,993 $3.2 Million

Others Institutions Holding ABBV

# of Institutions

3,654

Shares Held

1.24B

Call Options Held

15.5M

Put Options Held

11.6M

View Full List

About AbbVie Inc.

Ticker ABBV
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 1,768,099,968
Market Cap $294B
Description
AbbVie Inc. discovers, develops, manufactures, and sells pharmaceuticals in the worldwide. The company offers HUMIRA, a therapy administered as an injection for autoimmune and intestinal Behçet's diseases; SKYRIZI to treat moderate to severe plaque psoriasis in adults; RINVOQ, a JAK inhibitor for the treatment of moderate to severe active rheuma...

More about ABBV

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Hengehold Capital Management LLC, based on Form 13F filings with the SEC.

News

Stay updated on Hengehold Capital Management LLC with notifications on news.

Account

Hengehold Capital Management LLC Abb Vie Inc. Transaction History